Get it on Google Play

Abivax reports positive phase 3 ulcerative colitis trial results

July 22, 2025 4:05 PM EDT Send to a Friend
Abivax SA (Euronext Paris: ABVX / NASDAQ: ABVX) announced positive results from two ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login